302 related articles for article (PubMed ID: 9585379)
1. Plasma GH responses to GHRH, arginine, L-dopa, pyridostigmine, sequential administrations of GHRH and combined administration of PD and GHRH in Turner's syndrome.
Hanew K; Tanaka A; Utsumi A
J Endocrinol Invest; 1998 Feb; 21(2):72-7. PubMed ID: 9585379
[TBL] [Abstract][Full Text] [Related]
2. [The GHRH test in Turner's syndrome].
Saggese G; Cesaretti G; Cioni C
Minerva Pediatr; 1991 Jun; 43(6):437-43. PubMed ID: 1886528
[TBL] [Abstract][Full Text] [Related]
3. Evidence against depletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: studies with GH-releasing hormone, pyridostigmine, and arginine.
Valcavi R; Valente F; Dieguez C; Zini M; Procopio M; Portioli I; Ghigo E
J Clin Endocrinol Metab; 1993 Sep; 77(3):616-20. PubMed ID: 8103770
[TBL] [Abstract][Full Text] [Related]
4. Further evidence of cholinergic impairment of the neuroendocrine control of the GH secretion in Down's syndrome.
Beccaria L; Marziani E; Manzoni P; Arvat E; Valetto MR; Gianotti L; Ghigo E; Chiumello G
Dement Geriatr Cogn Disord; 1998; 9(2):78-81. PubMed ID: 9524798
[TBL] [Abstract][Full Text] [Related]
5. Cholinergic modulation of growth hormone responses to growth hormone-releasing hormone in uraemic patients on peritoneal dialysis.
Díez JJ; Iglesias P; Selgas R; Bajo MA; Aguilera A
Clin Endocrinol (Oxf); 2000 Nov; 53(5):587-93. PubMed ID: 11106919
[TBL] [Abstract][Full Text] [Related]
6. Decreased growth hormone response to growth hormone-releasing hormone in Turner's syndrome: relation to body weight and adiposity.
Reiter JC; Craen M; Van Vliet G
Acta Endocrinol (Copenh); 1991 Jul; 125(1):38-42. PubMed ID: 1872123
[TBL] [Abstract][Full Text] [Related]
7. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
Ghigo E; Imperiale E; Boffano GM; Mazza E; Bellone J; Arvat E; Procopio M; Goffi S; Barreca A; Chiabotto P
J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
[TBL] [Abstract][Full Text] [Related]
8. Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome.
Procopio M; Invitti C; Maccario M; Grottoli S; Cavagnini F; Camanni F; Ghigo E
Int J Obes Relat Metab Disord; 1995 Feb; 19(2):108-12. PubMed ID: 7735336
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone response to growth hormone releasing hormone 1-40 in Turner's syndrome.
Cappa M; Loche S; Borrelli P; Corda R; Marini R; Porcedda C; Pintor C
Horm Res; 1987; 27(1):1-6. PubMed ID: 3114115
[TBL] [Abstract][Full Text] [Related]
10. Influence of estrogen administration on growth hormone response to GHRH and L-Dopa in patients with Turner's syndrome.
Schober E; Frisch H; Waldhauser F; Bieglmayr C
Acta Endocrinol (Copenh); 1989 Apr; 120(4):442-6. PubMed ID: 2497615
[TBL] [Abstract][Full Text] [Related]
11. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
Cordido F; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1989 Feb; 68(2):290-3. PubMed ID: 2493023
[TBL] [Abstract][Full Text] [Related]
12. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
Procopio M; Maccario M; Savio P; Valetto MR; Aimaretti G; Grottoli S; Oleandri SE; Baffoni C; Tassone F; Arvat E; Camanni F; Ghigo E
Panminerva Med; 1998 Mar; 40(1):13-7. PubMed ID: 9573747
[TBL] [Abstract][Full Text] [Related]
13. The role of the cholinergic pathway in growth hormone feedback.
Kelijman M; Frohman LA
J Clin Endocrinol Metab; 1991 May; 72(5):1081-7. PubMed ID: 1902484
[TBL] [Abstract][Full Text] [Related]
14. The role of endogenous GHRH in arginine-, insulin-, clonidine- and l-dopa-induced GH release in normal subjects.
Hanew K; Utsumi A
Eur J Endocrinol; 2002 Feb; 146(2):197-202. PubMed ID: 11834428
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone response to hexarelin, growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen in prepubertal and early pubertal short children.
Guzzaloni G; Grugni G; Morabito F
Minerva Endocrinol; 1998 Dec; 23(4):99-104. PubMed ID: 10361807
[TBL] [Abstract][Full Text] [Related]
16. The enhancing effect of pyridostigmine on the GH response to GHRH undergoes an accelerated age-related reduction in Down syndrome.
Arvat E; Gianotti L; Ragusa L; Valetto MR; Cappa M; Aimaretti G; Ramunni J; Grottoli S; Camanni F; Ghigo E
Dementia; 1996; 7(5):288-92. PubMed ID: 8872421
[TBL] [Abstract][Full Text] [Related]
17. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
Procopio M; Maccario M; Savio P; Valetto MR; Aimaretti G; Grottoli S; Oleandri SE; Baffoni C; Tassone F; Arvat E; Camanni F; Ghigo E
Minerva Endocrinol; 1999; 24(3-4):107-11. PubMed ID: 10953725
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactive growth hormone-releasing hormone (IR-GHRH) in the feto-placental circulation and differential effects of L-dopa, L-arginine and somatostatin-14 on the plasma levels of IR-GHRH in normal adults.
Saito H; Hosoi E; Yamasaki R; Kameyama K; Irahara M; Ohno Y; Saito S
Horm Metab Res; 1997 Apr; 29(4):184-9. PubMed ID: 9178029
[TBL] [Abstract][Full Text] [Related]
19. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children.
Ghigo E; Bellone J; Aimaretti G; Bellone S; Loche S; Cappa M; Bartolotta E; Dammacco F; Camanni F
J Clin Endocrinol Metab; 1996 Sep; 81(9):3323-7. PubMed ID: 8784091
[TBL] [Abstract][Full Text] [Related]
20. Arginine potentiates the GHRH- but not the pyridostigmine-induced GH secretion in normal short children. Further evidence for a somatostatin suppressing effect of arginine.
Ghigo E; Bellone J; Mazza E; Imperiale E; Procopio M; Valente F; Lala R; De Sanctis C; Camanni F
Clin Endocrinol (Oxf); 1990 Jun; 32(6):763-7. PubMed ID: 1974484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
